Member States should be allowed, therefore, following scientific recommendations, to define restrictive conditions for their use, for example conditioning their prescription to the realisation of antimicrobial susceptibility testing to ensure that there is no other antimicrobials available that are sufficiently effective or appropriate to treat diagnosed disease.
Ba cheart a cheadú do na Ballstáit tar éis moltaí eolaíocha, coinníollacha sriantacha a shainiú lena n-úsáid, mar shampla a n-oideas a riochtú chun tástáil inghlacthachta ábhar frithmhiocróbach a chur i gcrích chun a áirithiú nach bhfuil aon fhrithmhiocróbacha eile ar fáil atá éifeachtach nó iomchuí go leor chun galar diagnóisithe a chóireáil.